Small Cap Feast

Small Cap Feast – 07 February 2020

Set Menu AIM:

Total number of AIM Companies (Incl Susp):

Total number of AIM Companies trading: *
* As at

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): *

Total number of NEX Growth Market Companies trading: *
* As at

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): *

Total number of Standard List Companies trading: *
* As at

Dish of the Day:

Calisen Group. CLSN.L Main Mkt  Premium. Owner and manager of essential energy infrastructure assets through its subsidiaries Calvin Capital and Lowri Beck . Consolidated FY Dec 18 revenue £162.1m and operating profit £25.4m. Raising up to £300m in primary plus £29m partial vendor sale.  Mkt cap £1.32bn


Off the Menu:

cloudBuy has left Aim. Abal has left AIM pursuant to AIM 41. Intends to relist on the Standard List subject to an acquisition. Hansteen has left the Main Market following an acquisition.


Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?


Intention to float by Gemfields Group. No Capital Raise. Currently listed on JSE. (GML:JNB) at circa £122m.  The Group’s key producing assets, the Kagem emerald mine in Zambia  (believed to be the world’s single largest producing emerald mine) and the Montepuez ruby mine in Mozambique (one of the most significant recently discovered ruby deposits in the world), are both expected to have long mine-lives with potential for expansion. Also owns the  Faberge brand. Due Valentines Day 2020.

Main Market (Standard List)

The Proof Of Trust has announced its intention to list on the Standard Market.  The Blockchain based business, owns patents to a protocol which facilitates dispute resolution based upon smart contract disputes.  Transaction details TBC.

Main Market (Premium)

Ninety One –proposed demerger and public listing of  Investec’s  global asset management business on LSE and JSE. 30 Sep 2019 AUM £121bn. Sale of existing shares. Expected free float of >60%. Due 16 march.

Cabot Square—Closed ended investment fund focussed on alternative assets and asset manager. Looking to raise £200m.  Will target investment opportunities that are expected to generate an attractive risk adjusted return and that can also make a positive ESG impact by focusing on some of the biggest challenges facing societies and economies.  Due 14 Feb.

The Global Sustainable Farmland Income Trust will invest in a diversified portfolio of operational farmland assets located in major agricultural markets including the United States, Europe, New Zealand, Australia and certain countries within Latin and South America. Raising up to $300m.   Due 28 February.

Investment firm Nippon Active Value fund is seeking to raise up to £200m at an issue price of 100p per share via an IPO.   The company aims to invest in a portfolio of quoted Japanese stocks with market capitalisations of up to $1bn.   First day of dealings expected early February.

NEX Exchange

Zapp Scooters, a developer and manufacturer of electric two-wheeled vehicles announced its intention to IPO on the NEX Exchange Growth Market.  The Company intends to raise up to £3.5m. Admission is expected to occur on NEX in February 2020.


Breakfast Buffet

NQ Minerals (NEX:NQMI) 8.25p £27.6m

The base and precious metals producer from its flagship Hellyer Gold Mine (“Hellyer”) in Tasmania, Australia, advises that further to the news release of 7 January 2020, that Mineral Resources Tasmania has approved the transfer of the 100% rights to the 46 km(2) Mt Block permit (EL48/2003), which surrounds the Hellyer Mining Lease. NQ purchased the Mt Block from Bass Metals Ltd.

David Lenigas, Chairman of NQ Minerals, commented:

“This is a very positive development for the Company as the Mt Block increases NQ’s license holding three-fold around the Hellyer Mine. This tenement is underexplored and has the potential to host new mineralisation close to NQ’s Hellyer processing plant.”


Gowin New Energy (NEX:GWPT) 0.65p £1.8m

 An application has been made for a new class of shares for the issue of up to GBP5,000,000 2% Cumulative Preference Shares, with a nominal value of GBP0.02 each, of the Company (the “Preference Share”). The new Preference Shares have been admitted today to trading on the NEX Exchange Growth Market.

The Company has received GBP250,000 from an investor Mr Wen Sheng-Tung to issue 12,500,000 2% Preference Shares of GBP0.02 each. The proceeds of the Preference Shares will be utilized in whole, save for amounts retained to meet expenses, to provide loan finance to Goyoung International Company Limited . Goyoung was incorporated in May 2019 with an issued share capital of US$ 6,500.00. Goyoung was set-up to operate the new Tea Business and is currently 100 per cent. owned by Mr Chen Chih-Lung and Mr Wen Sheng-Tung, each holding 50% of the shares in Goyoung.


Autins Group (AUTG.L) 20p £8.1m

AGM Statement from the designer, manufacturer and supplier of acoustic and thermal insulation solutions for the automotive sector.

FY2019 was one of recovery and continued strategic focus for the Group.  Autins ended the year in a stronger position both operationally and financially and can look ahead with confidence, despite the significant challenges faced by the global automotive market.

In addition to the successful £3.3m placing of new shares in August 2019, the Group entered into a £1.5m five-year debt facility with the Midlands Engine Investment Fund in January 2020 to provide longer term capital which replaces certain of the Group’s existing facilities.

The Group’s financial performance for FY2020 is currently in line with management expectations.


DP Poland (DPP.L) 10p £24.7m

Full year trading update for 2019, unaudited. DP Poland, through its wholly owned subsidiary DP Polska S.A., has the exclusive right to develop, operate and sub-franchise Domino’s Pizza stores in Poland.

System Sales up 13%. Like-for-likes up 3% for the year, up 6% in H2. 82% of delivery sales ordered online. 69 stores.

Cash at bank of £3.6m as at 31 December 2019 (£2.0m as at 31 December 2018)

“While we continue to experience the impact of competition and labour inflation particularly, we expect to continue to see the positive effects of our well-received marketing campaign, our strong digital presence, and the strength of the Domino’s reputation for quality and service”.


Watchstone (WTG.L) 150p £69.2m

 The Canadian subsidiary, Quindell Services Inc. has completed the sale of PT Healthcare Solutions Corp. and other subsidiaries forming its Canadian Healthcare services  business to 11628542 Canada Inc. a wholly owned subsidiary of LM Holdings Corp. 

As per RNS of 17 September 2019 the initial consideration is C$36.2m.


Yew Grove REIT (YEW.L) 96c €107m

Yew Grove REIT plc (LSE:YEW, Euronext:YEW), which owns a diversified portfolio of Irish commercial property assets, further to the announcement on 19 December 2019, has now completed the acquisition of a portfolio of six office buildings at Millennium Park, Naas, County Kildare. The purchase price for the Portfolio is EUR25.3 million, which represents a net initial yield of 5.8 per cent. after accounting for purchase costs. The Portfolio has reversionary potential expected to yield in excess of 9 per cent.


CVS Group (CVS.L) p £m

HY Dec 19 trading update from one of the UK’s leading providers of integrated veterinary services

The improved trading performance delivered in the second half of the financial year to 30 June 2019, and the encouraging start to the new financial year, as announced at the time of the Annual General Meeting on 28 November 2019, has continued for the remainder of the half year to 31 December 2019.

In H1 2020, the Group’s total sales increased by 15.0% and like-for-like sales1 (“LFL”) increased by 8.4% . CVS expects to report H1 2020 Adjusted EBITDA  that is materially above that delivered in H1 2019 .


Novacyt (NCYT.L) 48p £29m

The international specialist in clinical diagnostics, provides an update following the launch of its research use only (RUO) test for novel coronavirus (2019-nCoV), which has been developed by its subsidiary Primerdesign as a direct response to the recent outbreak of the respiratory virus in China.

Since the World Health Organization declared the 2019-nCoV outbreak a global emergency on the 30 January 2020, the Company has seen strong demand for its nCoV test, which was launched on 31 January 2020. To date, Primerdesign has received orders for 33,000 tests and requests for quotations for another 32,000 tests from over 30 countries, with a high conversion rate from quotations to orders. The Directors believe the Company is well placed to support the growing global demand for nCoV testing.

The Company is planning to launch a CE-Mark approved nCoV test in the week commencing 17 February.


Midwich Group (MIDW.L) 530p £424m

The specialist audio visual distributor to the trade market with operations across the UK and Ireland, Continental Europe and Asia Pacific, has acquired the entire issued share capital of Starin Marketing, Inc, a specialist value-add AV distributor in the US for an enterprise value of up to $46.1m (£35.7m) . Intends to raise gross proceeds of £39.7m at 500pvia an accelerated bookbuild. For the year ended 31 December 2019, Starin delivered unaudited revenue of $222.7m, gross profit of $29.6m and EBITDA of $6.1m.


Thalassa (THAL.L) 63p £10.2m

The Board of Thalassa is pleased to announce that its wholly owned subsidiary, id4, has won the Best Compliance Solution Award at the prestigious “WealthBriefing Swiss Awards 2020”, held in Geneva on Thursday, 6 February 2020.

This award reflects the innovative approach developed by id4 to support financial institutions in meeting increasing compliance requirements in Anti Money Laundering (AML) and in Know Your Customer (KYC) regulations.


Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.